Favorable Prognosis for Syncope Patients Discharged From ER

Share this content:
Favorable Prognosis for Syncope Patients Discharged From ER
Favorable Prognosis for Syncope Patients Discharged From ER

THURSDAY, Nov. 2, 2017 (HealthDay News) -- Most patients presenting to the emergency department (ED) with a primary diagnosis of syncope are discharged and have a favorable prognosis, and though total costs to care for discharged syncope patients are high, cost per patient is lower compared with hospitalized patients, according to a study published online Nov. 1 in JACC: Clinical Electrophysiology.

Roopinder K. Sandhu, M.D., M.P.H., from the University of Alberta in Canada, and colleagues examined outcomes and costs for 51,831 consecutive patients presenting to the ED with a primary diagnosis of syncope from 2006 to 2014.

The researchers found that 6.6 percent of patients were hospitalized and discharged with a primary diagnosis of syncope (cohort 1), 8.7 percent were hospitalized and discharged with a primary diagnosis other than syncope (cohort 2), and 84.7 percent were discharged home from the ED with a diagnosis of syncope (cohort 3). There was variation in 30-day ED revisits for syncope from 1.2 to 2.4 percent for cohorts 2 and 1, respectively; readmission rates were below 1 percent among the cohorts. Short- and long-term mortality rates were highest and lowest for cohorts 2 and 3, respectively (30-day mortality: 1.2, 5.2, and 0.4 percent for cohorts 1, 2, and 3, respectively; one-year mortality: 9.2, 17.7, and 3 percent, respectively). The total cost of syncope presentation was $534.8 million ($76.7 million, $139.4 million, and $318.7 million for cohorts 1, 2, and 3, respectively).

"Further research is needed for cost-saving strategies across all cohorts," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »